StockData
Trinity Biotech PLC logo

Trinity Biotech PLC (TRIB) stock

TRIBNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 1/30
$5.83−0.18 (-3.08%)

Close on Nov 18, 2026Market cap $108.99MP/E –Yield –

Trinity Biotech operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was -$15.79M. The highest annual figure on record is $13.51M in fiscal 2015.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$15.79M–
FY2024Dec 31, 2024-$21.17M–
FY2023Dec 31, 2023-$27.05M–
FY2022Dec 31, 2022-$19.35M-591.3%
FY2021Dec 31, 2021$3.94M+4702.4%
FY2020Dec 31, 2020$82.00K–
FY2019Dec 31, 2019-$24.11M–
FY2018Dec 31, 2018-$20.23M–
FY2017Dec 31, 2017-$37.67M–
FY2016Dec 31, 2016-$39.85M-395.0%
FY2015Dec 31, 2015$13.51M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2018Jun 30, 2018$1.73M–
Q2 FY2017Jun 30, 2017$1.83M–

More Trinity Biotech figures

See a number that looks wrong?